menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Gilead cracks down on HIV fraud with new motion

    BIOSPACE

    Gilead’s converting Truvada PrEP users to Descovy faster than expected

    FIERCE PHARMA

    Who Owns H.I.V.-Prevention Drugs? The Taxpayers, U.S. Says

    NY TIMES

    Gilead elevates M&A architect Dickinson to CFO. Could more deals be next?

    FIERCE PHARMA

    AbbVie, Gilead and Allergan 3-peat with September`s top pharma TV spending

    FIERCE PHARMA

    U.S. Reps question Gilead`s donation of free HIV drug Truvada

    FIERCE PHARMA

    HIV prevention pill recommended for healthy people at risk

    REUTERS

    Gilead to donate 2.4M bottles of Truvada in push to limit HIV infections

    FIERCE PHARMA

    Gilead`s $3B-per-year Truvada to face generics a year early

    FIERCE PHARMA

    List of centrally authorised products requiring a notification of a change for update of annexes

    EMA

    AIDS charity lambasts “ethically challenged” Gilead over price hikes

    PHARMAFILE

    Gilead Sciences Falls as Antiviral Drug Sales Miss Mark

    BLOOMBERG

    Scotland first UK nation to routinely offer HIV PrEP

    PHARMA TIMES

    Truvada (Emtricitabine & Tenofovir disoproxil fumarate): Gilead & Emory Univ. v. Amneal

    PATENT LITIGATION

    Gilead`s low-dose, high-impact HIV drug heads to the FDA

    SAN FRANSISCO BUSINESS TIMES

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.